Clin2
NCT06421220Possibly a fitNot yet recruiting

Green dye guidance for stomach cancer surgery

Gastric Cancer

Part of Cancer, Digestive system clinical trials.

This trial tests if a green dye helps surgeons see and remove lymph nodes more clearly during 3D laparoscopic stomach cancer surgery. The goal is to confirm the dye's safety and benefit for patients undergoing this procedure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
484 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with stomach cancer that has not spread to distant organs or directly into the pancreas or spleen.
  • Your cancer is at a stage where surgery with lymph node removal is appropriate.
  • You are in good physical condition (ECOG 0 or 1) and have low to moderate surgical risk (ASA I-III).
  • You have not had any previous stomach surgery or upper abdominal surgery (except gallbladder removal by laparoscopy).
  • You have not received chemotherapy or radiation before surgery, and you have not had another cancer in the last 5 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06945718Recruiting
Green dye test for gastric cancer surgery

This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.

Fuzhou, Fujian
NCT06755554Recruiting· Phase 3
Green dye to guide lymph node removal in stomach cancer surgery

This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.

Kyiv
NCT05618821Recruiting· Phase 2
Indocyanine green dye during stomach surgery for leftover cancer

This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.

Fuzhou, Fujian
NCT06892392Not yet recruiting
Green dye for lymph node removal in stomach cancer

This trial uses a green dye to help surgeons see and remove lymph nodes during keyhole surgery for stomach cancer. The goal is to improve the accuracy of lymph node removal.

Pamplona, Navarre
NCT06161207Recruiting· Phase 3
Laparoscopic surgery for stomach cancer using 3D and dye

This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.

Fuzhou, Fujian
NCT05369117Not yet recruiting
Fluorescent camera surgery for proximal stomach cancer

This study uses a special dye and a fluorescent camera during keyhole (laparoscopic) surgery to help doctors see and treat proximal (upper) stomach cancer. It may improve how well surgeons can find the tumor area during the operation.

Hear when a new Gastric Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.